Evidence map›Paper›PMID 32647774›Full record

ArticleKidney international reports2020

Elevated Fibroblast Growth Factor 23 and Decreased Klotho Levels Are Associated With Diastolic Dysfunction in CKD G4-5D Patients.

Ludmila Yu Milovanova, Mikhail Yu Shvetsov, Svetlana Yu Milovanova, Lidia V Lysenko Kozlovskaya, Elena S Kamyshova, Marina V Taranova, Marina V Lebedeva, Vladimir D Beketov, Tatyana V Androsova, Vasiliy V Kozlov and 2 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. The Authors Reply.Kidney international reports · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ludmila Yu MilovanovaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Mikhail Yu ShvetsovSechenov First Moscow State Medical University, Moscow, Russian Federation.
Svetlana Yu MilovanovaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Lidia V Lysenko KozlovskayaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Elena S KamyshovaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Marina V TaranovaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Marina V LebedevaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Vladimir D BeketovSechenov First Moscow State Medical University, Moscow, Russian Federation.
Tatyana V AndrosovaSechenov First Moscow State Medical University, Moscow, Russian Federation.
Vasiliy V KozlovSechenov First Moscow State Medical University, Moscow, Russian Federation.
Vladimir A ReshetnikovSechenov First Moscow State Medical University, Moscow, Russian Federation.
Sergey V MoiseevSechenov First Moscow State Medical University, Moscow, Russian Federation.
Sechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32647774
PMCPMC7335966
OpenAlexW3021964990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.